FDA Drug Review, Surveillance Offices Agree To Share Regulatory Authority Over Safety
This article was originally published in The Pink Sheet Daily
Executive Summary
Memorandum of understanding gives Office of Surveillance and Epidemiology a greater voice on regulatory issues related to drug safety.
You may also be interested in...
FDA “Safety First” Implementation: Drug Review, Drug Safety Offices To Meet Regularly
Topics of discussion for joint meetings will range from broad regulatory questions to specific issues about an NDA or BLA.
Pazdur’s Big Moment: ‘Project Odyssey’ Webinar Gives Oncology Chief External Buy-In On His Ideas To Revamp ODAC
OCE Director Richard Pazdur is known for cultivating 'Pazdur moments' during advisory committees when he feels the conversation has gone off track. A recent webinar with ODAC members created a perfect opportunity to promote his agenda.